Non-invasive Diagnosis of Parkinson's Disease
NCT07201610 · Status: NOT_YET_RECRUITING · Type: OBSERVATIONAL · Enrollment: 60
Last updated 2025-10-01
Summary
This study will investigate new, non-invasive methods to help diagnose Parkinson's disease. Researchers will use advanced eye imaging (hyperspectral retinal photography and OCT), computerized memory and thinking tests, and voice analysis to identify patterns linked to Parkinson's. The goal is to improve early and accurate diagnosis of Parkinson's disease without the need for spinal taps or invasive tests.
Conditions
- Parkinsons Disease (PD)
Sponsors & Collaborators
-
Region Blekinge
collaborator UNKNOWN -
Blekinge Institute of Technology
lead OTHER
Eligibility
- Min Age
- 60 Years
- Max Age
- 80 Years
- Sex
- ALL
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2025-10-16
- Primary Completion
- 2025-12-16
- Completion
- 2025-12-16
More Related Trials
-
Imaging Studies of Cognitive Impairment in Parkinson s Disease
NCT01862744 ·Status: COMPLETED
-
Retinal Abnormalities as Biomarker of Disease Progression and Early Diagnosis of Parkinson Disease
NCT02640339 ·Status: COMPLETED
-
Retinal Function in Parkinson's Disease
NCT01010074 ·Status: UNKNOWN
-
Neuroimaging of Parkinson's
NCT07024875 ·Status: RECRUITING
-
Measures of Motor Impairment in Early Parkinson's Disease
NCT00291265 ·Status: COMPLETED
-
Investigating Central Mechanisms of Overactive Bladder in Adults With Parkinson's Disease
NCT02783014 ·Status: COMPLETED
-
PET/MR Imaging in Patients With Short and Long Standing Parkinson's Disease
NCT02801110 ·Status: UNKNOWN
-
A Study of Neurophysiologic Changes in Individuals With Parkinson's Disease
NCT00117195 ·Status: COMPLETED
-
The Effects of fNIRS-based Neurofeedback Training on Balance and Gait in Parkinson's Disease
NCT05800470 ·Status: RECRUITING ·Phase: NA
-
Imaging and Genetic Biomarkers of Parkinson Disease (PD) Onset and Progression in High-risk Families
NCT00273351 ·Status: COMPLETED ·Phase: PHASE2
-
Development of Digital Diagnostic Devices for Parkinson's Disease
NCT06663826 ·Status: RECRUITING
-
Spectroscopy in Parkinson Disease
NCT01005030 ·Status: UNKNOWN
-
Attention and Eye Movement in Parkinson's Disease
NCT06899022 ·Status: RECRUITING ·Phase: NA
-
Identifying Biomarkers of Parkinson's Disease Using Magnetic Resonance Imaging (MRI)
NCT01888185 ·Status: COMPLETED
-
Serotonin Release in Premotor and Motor PD
NCT05516732 ·Status: RECRUITING
-
Complex Eye Movements in Parkinson's Disease and Related Movement Disorders
NCT04925622 ·Status: COMPLETED
-
DTI in Evaluation of Parkinsons Disease
NCT05231356 ·Status: UNKNOWN
-
The Differential Diagnosis of Parkinson's Disease and Parkinsonism by Positron-emission Tomography
NCT01824056 ·Status: COMPLETED ·Phase: PHASE2
-
Development of a Novel 18F-DTBZ PET Imaging as a Biomarker to Monitor Neurodegeneration of PARK6 and PARK8 Parkinsonism
NCT01759888 ·Status: COMPLETED ·Phase: PHASE2
-
Deep Brain Stimulation for Visuomotor Function in Parkinson's Disease
NCT05400499 ·Status: RECRUITING
-
MRI Study of Brain Activity in Healthy Adults and Individuals With Parkinsonism and Rapid Eye Movement Disorder.
NCT01547481 ·Status: COMPLETED
-
Development of Cognitive Assessment Tools in Parkinson Disease
NCT00556764 ·Status: COMPLETED ·Phase: EARLY_PHASE1
-
Imaging Biomarkers of Progression of Mobility Impairment in Parkinson Disease
NCT01106976 ·Status: COMPLETED
-
Predictive Value of Multimodal MRI in Parkinson's Disease
NCT05003206 ·Status: UNKNOWN ·Phase: NA
-
Relationship Between Symptoms, Retinal Morphology, and the Nigrostriatal Dopamine System in Parkinson's Disease
NCT02443779 ·Status: COMPLETED